Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Caribou Biosciences Inc.’s current trading price is -65.50% away from its 52-week high, while its distance from the 52-week low is 12.35%. The stock’s price range over this period has fluctuated between $4.05 and $13.19. The company, operating within the financial sector, had a trading volume of approximately 0.56 million for the day, which was noticeably higher than the average daily share volume of 0.54 million over the last 3 months.
The stock price for Caribou Biosciences Inc. (CRBU) currently stands at $4.55. The stock experienced a substantial increase in the last session, hitting $4.90 after starting at $4.90. The stock’s lowest price was $4.38 before closing at $4.93.
25-cent Stock Takes $11T Commodities Sector Digital
One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.
All the details are in the FREE online report you can get here.
Caribou Biosciences Inc. experienced a rather shaky stock market performance. The highest value in the past year was recorded at $13.19 on 09/15/22 and the lowest value was $4.05 on 04/28/23.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Caribou Biosciences Inc. (CRBU) has experienced a quarterly decline of -25.41% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 274.05M and boasts a workforce of 137 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 5.60, with a change in price of -1.50. Similarly, Caribou Biosciences Inc. recorded 517,307 in trading volume during the last 100 days, posting a change of -24.79%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for CRBU stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
CRBU Stock Stochastic Average
Today, Caribou Biosciences Inc.’s raw stochastic average for the past 50 days stands at 33.11%, indicating a decline from the raw stochastic average of the last 20 days, which was 41.32%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 69.41% and 64.01% respectively.
CRBU Stock Price Performance Analysis
Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. This year’s metric has recorded a Price decrease of -27.55%. However, over the past six months, we’ve seen a stronger performance of -48.93%. The price of CRBU fallen by 5.81% over the last 30 days. And in the last five days, it has surged by 3.64%.